OP9: Collagen/Chitosan Dermal Substitute Enriched by Hyperstable FGF2: 4 Years of Development

Abstract

amniotic membrane manufactured by the patented technology AMNIPUR, preserving regenerative properties of the amniotic membrane. AM is already applied on a Sanatyl carrier, so it is easily applied on wound bed covered by secondary sterile gauze. RESULTS:We observed excellent biocompatibility and rapid acceleration of epithelialization and wound healing together with outstanding long-term results within all patients with burns and toxic epidermal necrolysis treated with Amnioderm at our department.CONCLUSION: Successful therapy of various types of wounds with AM opens further wide possibilities for clinical application with superior outcomes for our patients.